Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28426 - 28450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	GALNT10	55568	downregulated	Cytarabine results in decreased expression of GALNT10 mRNA	5q33.2	A21886
Cytarabine	Approved Investigational	GAP43	2596	upregulated	Cytarabine results in increased expression of GAP43 mRNA	3q13.31	A21886
Cytarabine	Approved Investigational	GATA5	140628	downregulated	Cytarabine results in decreased expression of GATA5 mRNA	20q13.33	A21886
Cytarabine	Approved Investigational	GBP4	115361	downregulated	Cytarabine results in decreased expression of GBP4 mRNA	1p22.2	A21886
Cytarabine	Approved Investigational	GCA	25801	downregulated	Cytarabine results in decreased expression of GCA mRNA	2q24.2	A21886
Cytarabine	Approved Investigational	GCNT2	2651	downregulated	Cytarabine results in decreased expression of GCNT2 mRNA	6p24.3-p24.2	A21886
Cytarabine	Approved Investigational	GHR	2690	downregulated	Cytarabine results in decreased expression of GHR mRNA	5p13.1-p12	A21886
Cytarabine	Approved Investigational	GLS	2744	downregulated	Cytarabine results in decreased expression of GLS mRNA	2q32.2	A21886
Cytarabine	Approved Investigational	GNB3	2784	downregulated	Cytarabine results in decreased expression of GNB3 mRNA	12p13.31	A21886
Cytarabine	Approved Investigational	GPER1	2852	downregulated	Cytarabine results in decreased expression of GPER1 mRNA	7p22.3	A21886
Cytarabine	Approved Investigational	GPM6A	2823	upregulated	Cytarabine results in increased expression of GPM6A mRNA	4q34.2	A21886
Cytarabine	Approved Investigational	GPR19	2842	upregulated	Cytarabine results in increased expression of GPR19 mRNA	12p13.1	A21886
Cytarabine	Approved Investigational	GPR83	10888	downregulated	Cytarabine results in decreased expression of GPR83 mRNA	11q21	A21886
Cytarabine	Approved Investigational	GPRC5C	55890	downregulated	Cytarabine results in decreased expression of GPRC5C mRNA	17q25.1	A21886
Cytarabine	Approved Investigational	GRIA2	2891	upregulated	Cytarabine results in increased expression of GRIA2 mRNA	4q32.1	A21886
Cytarabine	Approved Investigational	GRK5	2869	upregulated	Cytarabine results in increased expression of GRK5 mRNA	10q26.11	A20985
Cytarabine	Approved Investigational	GRPR	2925	downregulated	Cytarabine results in decreased expression of GRPR mRNA	Xp22.2	A21886
Cytarabine	Approved Investigational	GSTCD	79807	upregulated	Cytarabine results in increased expression of GSTCD mRNA	4q24	A20985
Cytarabine	Approved Investigational	GTPBP1	9567	upregulated	Cytarabine results in increased expression of GTPBP1 mRNA	22q13.1	A20985
Cytarabine	Approved Investigational	GUCY1A3	2982	downregulated	Cytarabine results in decreased expression of GUCY1A3 mRNA	4q32.1	A21886
Cytarabine	Approved Investigational	GUSBP1	728411	upregulated	Cytarabine results in increased expression of GUSBP1 mRNA	5p14.3	A21886
Cytarabine	Approved Investigational	GYG2	8908	downregulated	Cytarabine results in decreased expression of GYG2 mRNA	Xp22.33	A21886
Cytarabine	Approved Investigational	H2AFJ	55766	downregulated	Cytarabine results in decreased expression of H2AFJ mRNA	12p12.3	A21886
Cytarabine	Approved Investigational	HAND1	9421	downregulated	Cytarabine results in decreased expression of HAND1 mRNA	5q33.2	A21886
Cytarabine	Approved Investigational	HAND2	9464	downregulated	Cytarabine results in decreased expression of HAND2 mRNA	4q34.1	A21886

Displaying entries 28426 - 28450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability